Aroa Biosurgery Ltd has released a press release.
Aroa Biosurgery Half Yearly Results H1 FY25
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Aroa Biosurgery
- September 2024 Quarterly Report and Appendix 4C
- June 2024 Quarterly Report and Appendix 4C
- FY24 Full Year Results Presentation
- FY24 Appendix 4E and Full Year Results
- March 2024 Quarterly Report and Appendix 4C
Later from Aroa Biosurgery
- Aroa Half Year Results Presentation
- December 2024 Quarterly Report and Appendix 4C
- March 2025 Quarterly Report and Appendix 4C
- AROA hits evidence milestone with real-world study validating the efficacy of Endoform in treating challenging venous leg ulcers.
- FY25 Appendix 4E and Full Year Results
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery